RxNorm 2569637 NDC Crossover

Skytrofa 9.1 MG Cartridge

Related NDC Codes to RxNorm Concept 2569637

The following NDC codes crossover to the RxNorm Concept 2569637. This list is useful when crossing over from a given RxNorm code and the user is trying to choose a drug or product included in the NDC directory.

NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Labeler Name	Status
73362-003	Skytrofa	Lonapegsomatropin-tcgd	Injection, Powder, Lyophilized, For Solution	Subcutaneous	Ascendis Pharma Endocrinology, Inc.	ACTIVE
73362-004	Skytrofa	Lonapegsomatropin-tcgd	Injection, Powder, Lyophilized, For Solution	Subcutaneous	Ascendis Pharma Endocrinology, Inc.	ACTIVE
73362-005	Skytrofa	Lonapegsomatropin-tcgd	Injection, Powder, Lyophilized, For Solution	Subcutaneous	Ascendis Pharma Endocrinology, Inc.	ACTIVE
73362-006	Skytrofa	Lonapegsomatropin-tcgd	Injection, Powder, Lyophilized, For Solution	Subcutaneous	Ascendis Pharma Endocrinology, Inc.	ACTIVE
73362-007	Skytrofa	Lonapegsomatropin-tcgd	Injection, Powder, Lyophilized, For Solution	Subcutaneous	Ascendis Pharma Endocrinology, Inc.	ACTIVE
73362-008	Skytrofa	Lonapegsomatropin-tcgd	Injection, Powder, Lyophilized, For Solution	Subcutaneous	Ascendis Pharma Endocrinology, Inc.	ACTIVE
73362-009	Skytrofa	Lonapegsomatropin-tcgd	Injection, Powder, Lyophilized, For Solution	Subcutaneous	Ascendis Pharma Endocrinology, Inc.	ACTIVE
73362-010	Skytrofa	Lonapegsomatropin-tcgd	Injection, Powder, Lyophilized, For Solution	Subcutaneous	Ascendis Pharma Endocrinology, Inc.	ACTIVE
73362-011	Skytrofa	Lonapegsomatropin-tcgd	Injection, Powder, Lyophilized, For Solution	Subcutaneous	Ascendis Pharma Endocrinology, Inc.	ACTIVE